Medtronic’s GI revenue reached $671 million, while renal care solutions revenue decreased low-double digits, according to the report.
Medtronic’s organic GI revenue also decreased by 11 percent. Medtronic’s overall revenue decreased 3 percent to $7.6 billion worldwide.
